Search Results - "Waggoner, S.E."

The use of novel PP2A activators in combination with PARP inhibitor for the treatment of high-grade serous ovarian cancer by Armstrong, A.J, Joseph, P, Nagaraj, A.B, Nagel, C.I, Nakayama, J, Waggoner, S.E, Zanotti, K.M, DiFeo, A, Narla, G

Get full text

Limited access safety lead-in of the MEK inhibitor trametinib in combination with GSK2141795, an AKT inhibitor, in patients with recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study by Westin, S.N, Sill, M, Coleman, R.L, Waggoner, S.E, Moore, K.N, Mathews, C.A, Jain, A, Modesitt, S.C, Schilder, R, Aghajanian, C

Get full text

The wnt/β-catenin-specific inhibitor, ICG-001, proves effective for the treatment of high-grade serous ovarian cancer in murine models through the targeting of cancer initiating cells by Connor, R.S, Nagaraj, A.B, Joseph, P, Mantilla, S, Kovalenko, O, Nagel, C.I, Nakayama, J, Waggoner, S.E, Zanotti, K.M, Singh, S, DiFeo, A

Get full text

Impact of smoking on survival among women treated with and without bevacizumab for advanced cervical cancer (CxCA): An NRG Oncology/Gynecologic Oncology Group study by Waggoner, S.E, Java, J, Monk, B.J, Michael, H, Penson, R.T, Leitao, M.M, Coleman, R.L, Mannel, R.S, Oaknin, A, Tewari, K.S

Get full text

A phase II trial of trebaninib (AMG 386), a selective angiopoietin 1/2 neuralizing peptibody in patients with persistent/recurrent carcinoma of the endometrium: A Gynecologic Oncology Group study by Sill, M, Tenney, M.E, Darus, C.J, Griffin, D, Werner, T.L, Waggoner, S.E, Behrens, R.J

Get full text

Small molecule activators of protein phosphatase 2A for the treatment of endometrial cancer by Joseph, P, Nagaraj, A.B, Armstrong, A, Resnick, K.E, Zanotti, K.M, Waggoner, S.E, Narla, G, DiFeo, A

Get full text

Adjuvant vaginal brachytherapy decreases the risk of vaginal recurrence in patients with stage I non-invasive uterine papillary serous carcinoma by Mahdi, H, Rose, P.G, Elshaikh, M, Munkarah, A.R, Isrow, D, Singh, S, Waggoner, S.E, Ali-Fehmi, R, Harding, J, Morris, R.T, DeBernardo, R

Get full text

Impact of surgical staging and adjuvant therapy on recurrence risk and outcome in stage I non-invasive uterine papillary serous carcinoma by DeBernardo, R, Elshaikh, M, Munkarah, A.R, Isrow, D, Singh, S, Waggoner, S.E, Ali, R, Harding, J, Morris, R.T, Moslemi-Kebria, M

Get full text

Identifying susceptibilities and pharmacodynamic biomarkers for mirvetuximab soravtansine in high-grade ovarian and endometrial cancer by Hopp, E., Joseph, P., Nakayama, J., Zanotti, K.M., Nagel, C.I., Waggoner, S.E., DiFeo, A.

Get full text

Universal germline screening for Lynch syndrome in endometrial cancer by Barrington, D.A., Cosgrove, C.M., Suarez, A.A., Waggoner, S.E., Nakayama, J., Andrews, S.J., Laskey, R., Pearlman, R., Hampel, H., Chassen, A., Cohn, D.E., Goodfellow, P.J.

Get full text

A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG Oncology/GOG study by Bae-Jump, V.L., Sill, M., Gehrig, P.A., Moxley, K., Hagemann, A.R., Waggoner, S.E., O'Cearbhaill, R.E., McDonald, M., DiSilvestro, P.A., Sperduto, P., Aghajanian, C.

Get full text

Cowpea mosaic virus nanoparticles for the treatment of high grade serous ovarian cancer: A patient-derived xenograft study by Dominick, C., Joseph, P., Ponting, E., Armstrong, A.J., Nakayama, J., Nagel, C.I., Zanotti, K., Waggoner, S.E., Steinmetz, N.F., DiFeo, A.

Get full text

The use of novel PP2A activators in combination withPARP inhibitor for the treatment of high-grade serous ovarian cancer by Armstrong, A.J., Joseph, P., Nagaraj, A.B., Nagel, C.I., Nakayama, J., Waggoner, S.E., Zanotti, K.M., DiFeo, A., Narla, G.

Get full text

Ultrasound guidance for placement of difficult intracavitary implants by Rotmensch, J, Waggoner, S E, Quiet, C

“…Placement of a radiation implant in patients with cervical cancer may be difficult because of distortion of the canal by tumor or fibrosis from previous…”
Get more information

Short-Term Effects of Nutrition and Exercise Intervention on Nutrient Intake and Body Weight in Obese Endometrial Cancer Surviviors: A Pilot Study by Kavanagh, M.B., Lerner, E., Frasure, H.E., Waggoner, S.E., von Gruenigen, V.E.

Get full text

Human cervical cells immortalized in vitro with oncogenic human papillomavirus DNA differentiate dysplastically in vivo by Waggoner, S E, Woodworth, C D, Stoler, M H, Barnes, W A, Delgado, G, DiPaolo, J A

“…Human papillomavirus (HPV) types 16 and 18 are associated with cervical dysplasia and carcinoma. In vitro integration of HPV-16 or HPV-18 DNA into cultured…”
Get more information